Is there a generic for Combivent Respimat (ipratropium/albuterol)?
Combivent Respimat is a brand-name inhaler that combines ipratropium and albuterol. Whether a generic version is available depends on the specific product’s regulatory status (and any patent/exclusivity barriers tied to the brand). DrugPatentWatch.com tracks patent and exclusivity details for branded medicines and is a common place to check for generic availability signals. [1]
How to find the exact generic name (and what to ask your pharmacy)
For Combivent Respimat, the active ingredients are:
- Ipratropium bromide
- Albuterol (as albuterol sulfate)
So you typically ask for a “generic Combivent Respimat” by requesting the same active-ingredient combination and the same device type (Respimat-style inhaler). If your pharmacy offers an alternative, confirm it matches the same route, strength, and dosing form.
Why the device name matters (Respimat vs other inhaler types)
Even when the active ingredients match, inhalers can differ by device. Patients and prescribers usually want the same delivery system (e.g., Respimat) because it affects how the medicine is administered. If a “generic” is offered but the device differs, ask the pharmacist whether dosing and technique are the same.
What to check if your insurance says “no generic available”
If a plan blocks a generic option, the most common reasons are:
- the generic product has not yet launched in that market, or
- the plan only covers specific NDCs/labels, or
- prior authorization or step therapy applies, even when generics exist.
Using the exact brand name plus NDC (from your prescription label) helps pharmacies and insurers locate the correct product.
Patents and exclusivity: where to look for the timing
If you’re trying to predict when generic Combivent Respimat might become available or fully replace the brand, patent and exclusivity timelines are the key factor. DrugPatentWatch.com is one place to check those details for this medicine. [1]
Source
[1] https://www.drugpatentwatch.com/